Contents of neuromediatory amino acids in human blood plasma during Parkinson's disease

   
Vitreshchak T.V.1 , Poleshchuk V.V.1, Piradov M.A.1

1. Institute of Neurology, Russian Academy of Medical Sciences
Section: Experimental/Clinical Study
PubMed Id: 15108632
Year: 2004  Volume: 50  Issue: 1  Pages: 92-99
Content of neurotransmitter amino acids before and after treatment with Не-Ne-laser was measured in blood of two groups of the Parkinson's disease patients distinguished by low (first group) and high (second group) activity of monoamine oxidase B and Cu/Zn-superoxide dismutase. An increase in taurine level at the early stage of the disease (first group of patients) suggests taurine may by a marker of compensatory abilities of the organism. The violation of the glutamate/taurine that balance at the later stages of the disease and its normalization following the laserotherapy accompanied with improvement of neurological symptoms.
Download PDF:
Citation:

Vitreshchak, T. V., Poleshchuk, V. V., Piradov, M. A. (2004). Contents of neuromediatory amino acids in human blood plasma during Parkinson's disease. Biomeditsinskaya khimiya, 50(1), 92-99.
References  
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)